NCT01995916

Brief Summary

This study has been funded by National Institute of Mental Health (NIMH) to compare two behavioral interventions for Menstrual Mood Disorders, including premenstrual dysphoric disorder (PMDD). Both of these interventions will be run in a group format, meaning that you will be part of a group of other women who have a menstrual mood disorder. Both of these interventions will be run by experienced mental health professionals and both interventions have been shown to be effective in reducing mood symptoms, increasing a sense of well-being, and helping individuals cope with stress. While it is expected that both interventions to be associated with some benefit, this study is designed to see which is better for women with a menstrual mood disorder.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 28, 2013

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 7, 2013

Completed
20 days until next milestone

First Posted

Study publicly available on registry

November 27, 2013

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2018

Completed
Last Updated

November 20, 2018

Status Verified

November 1, 2018

Enrollment Period

4.8 years

First QC Date

November 7, 2013

Last Update Submit

November 16, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Premenstrual Depression Symptomatology and Functional Impairment

    Premenstrual depression symptoms will be assessed prospectively before, during and for 6 months after the intervention using Daily Record of Severity of Problems (DRSPs). Functional impairment will be assessed via questionnaire at baseline, at 2 week intervals throughout the intervention, and monthly during the follow-up phase.

    Baseline, 8 weeks intervention, 6 months follow up

  • Change in Cold Pain Sensitivity

    Sensitivity to a cold pressor pain test (hand submerged in ice water) will be assessed in a laboratory setting before and after the intervention, and again 3 and 6 months later

    Lab 1 before the start of the intervention, Lab 2 immediately following intervention, Labs 3 and 4 during month 3 and 6 of follow up phase

Secondary Outcomes (2)

  • Change in premenstrual anxiety, irritability and total symptom severity

    Baseline, 8 weeks intervention, 6 months follow up

  • Change in sensitivity to the temporal summation of heat pain test

    Lab 1 before the start of the intervention, Lab 2 immediately following intervention, Labs 3 and 4 during month 3 and 6 of follow up phase

Study Arms (2)

Mindfulness Intervention

EXPERIMENTAL

Mindfulness Based Stress Reduction Intervention

Behavioral: Mindfulness Intervention

Social Support Group

ACTIVE COMPARATOR

Social Support Group Intervention

Behavioral: Social Support Group

Interventions

The Mindfulness Group will meet once a week for 2.5 hours for 8 weeks with a half day retreat.

Mindfulness Intervention

The Social Support Group will meet once a week for 2.5 hours for 8 weeks with a half day retreat.

Social Support Group

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Meets prospective criteria for a menstrual mood disorder, including PMDD
  • Depression symptom severity and functional impairment based on prospective symptom ratings for 2-3 cycles using the Daily Record of Severity of Problems (DRSP)
  • Clear remission of all symptoms during days 6-10
  • years of age
  • Regular menstrual cycles
  • Early life sexual or physical abuse (50% of sample) or no history of sexual or physical abuse (50% of sample)
  • Absence of current PTSD symptoms using the 17-item PTSD checklist (PCL)
  • th grade literacy level
  • Ability to give informed consent

You may not qualify if:

  • Current Axis I disorder or suicide ideation (histories of depression, anxiety, substance abuse, and eating disorders are allowed if in remission for \>2 years)
  • Premenstrual exacerbation of chronic disorders
  • In a current abusive relationship or residing with a former abuser
  • A lifetime history of suicide attempt, or suicidal thoughts or gestures within 5 years of study enrollment
  • Histories of bipolar or psychotic disorders
  • Age \< 18 or \> 55 years
  • Pregnancy or breastfeeding
  • Use of psychotropic, hormonal or other agents that alter mood or biological mediators
  • Current functional pain disorder
  • A history of meditation practice (2+ times/week for 15+ min; some yoga allowed)
  • Diabetes
  • BMI \< 18.5
  • Vigorous exercise
  • Stage 2 Hypertension
  • Any symptom item rated \>2 (moderate or higher) or a total score \> 24 on the PTSD checklist

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UNC Chapel Hill

Chapel Hill, North Carolina, 27599, United States

Location

Related Publications (1)

  • Andersen E, Geiger P, Schiller C, Bluth K, Watkins L, Zhang Y, Xia K, Tauseef H, Leserman J, Girdler S, Gaylord S. Effects of Mindfulness-Based Stress Reduction on Experimental Pain Sensitivity and Cortisol Responses in Women With Early Life Abuse: A Randomized Controlled Trial. Psychosom Med. 2021 Jul-Aug 01;83(6):515-527. doi: 10.1097/PSY.0000000000000889.

MeSH Terms

Interventions

Self-Help Groups

Intervention Hierarchy (Ancestors)

OrganizationsHealth Care Economics and Organizations

Study Officials

  • Susan Girdler, PhD

    UNC- Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 7, 2013

First Posted

November 27, 2013

Study Start

August 28, 2013

Primary Completion

May 31, 2018

Study Completion

May 31, 2018

Last Updated

November 20, 2018

Record last verified: 2018-11

Locations